Lineage Cell Therapeutics, Inc. insider trading
Every open-market purchase and sale by Lineage Cell Therapeutics, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $24,450 1 trade by 1 insider
3 months later: median −19.0% (−30.1% vs S&P 500) Insider sales, 5 years $0 0 trades by 0 insiders
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Lineage Cell Therapeutics, Inc.’s insiders pay?
From May 14, 2010 to March 12, 2026, 29 insiders reported 44 open-market purchases and 18 sales not made under a pre-set plan in Lineage Cell Therapeutics, Inc. After sales, the shares moved −47.8% against the index over 12 months (a negative figure means selling was the right call).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Broadwood Partners, L.P. | Director | 8 | — | — | 0 | — | February 8, 2024 |
| Kingsley Alfred D | See Remarks | 0 | — | — | 7 | — | August 2, 2017 |
| Bradsher Neal C | Director | 6 | — | — | 0 | — | March 25, 2022 |
| Broadwood Capital Inc | Director | 5 | — | — | 0 | — | January 28, 2025 |
| Culley Brian M | President and CEO | 4 | — | — | 0 | — | March 12, 2026 |
| Farrell Stephen C | Director | 4 | — | — | 0 | — | November 10, 2015 |
| West Michael D | Chief Executive Officer | 2 | — | — | 1 | — | July 23, 2014 |
| Peabody Robert | Sr. VP, COO, and CFO | 1 | — | — | 1 | — | July 23, 2014 |
| Russell Angus C. | Director | 1 | — | — | 1 | — | June 30, 2021 |
| Tew William P Phd | Chief Commercial Officer | 0 | — | — | 2 | — | June 17, 2014 |
| Amin Dipti | Director | 1 | — | — | 0 | — | March 29, 2022 |
| Andrews Deborah J | Director | 0 | — | — | 1 | — | June 30, 2021 |
| Bailey Don M | Director | 1 | — | — | 0 | — | February 8, 2024 |
| Burns Arnold I | Director | 1 | — | — | 0 | — | April 12, 2012 |
| Cartt Stephen Lahue | Director | 1 | — | — | 0 | — | August 18, 2015 |
| Cohen Abraham E | Director | 1 | — | — | 0 | — | April 12, 2012 |
| Garcia Peter S | Chief Financial Officer | 1 | — | — | 0 | — | March 19, 2012 |
| Gregg Valeta A | Director | 0 | — | — | 1 | −48.2% (1) | May 14, 2010 |
| Hernandez Alexandra | Sr Director Finance/Controller | 0 | — | — | 1 | — | April 1, 2021 |
| Hogge Gary S. | SVP,Clinical & Medical Affairs | 0 | — | — | 1 | — | December 30, 2021 |
| Jayasuriya Anula | Director | 1 | — | — | 0 | — | January 2, 2024 |
| Lichtinger Pedro | Director | 1 | — | — | 0 | — | April 12, 2012 |
| Mohanty Aditya P. | Co-Chief Executive Officer | 1 | — | — | 0 | — | August 22, 2017 |
| Mulroy Michael H. | Director | 1 | — | — | 0 | — | November 25, 2024 |
| Patton Stephana Eilene | General Counsel | 1 | — | — | 0 | — | August 22, 2017 |
| Schlachet David | Director | 1 | — | — | 0 | — | October 10, 2014 |
| Segall Judith | Vice President & Secretary | 0 | — | — | 1 | −47.3% (1) | November 23, 2010 |
| Seinberg Steven A | Chief Financial Officer | 0 | — | — | 1 | — | September 3, 2010 |
| Von Eschenbach Andrew C. | Director | 1 | — | — | 0 | — | August 14, 2013 |
← Back to Lineage Cell Therapeutics, Inc. · Funds · Politicians